Find stats on top websites
Business and Product Insights
Product Portfolio
Patient-Centric Medical Data Marketplace
HCP Outreach with Lab Data
Life Sciences Alerts
Prognos Health Key Value Propositions
Prognos Health's key value proposition is transforming complex, fragmented real-world clinical and genomic lab data into precise, actionable insights. This empowers pharmaceutical and biotech companies, especially in oncology and rare diseases, to optimize commercial strategies, accelerate product launches, and improve patient outcomes through data-driven decisions.
Prognos Health Brand Positioning
Prognos Health positions itself as the leading provider of actionable clinical and genomic lab data, specializing in RWD solutions for life sciences, particularly in oncology and rare diseases, enabling precise, timely insights.
Top Competitors
IQVIA
Symphony Health (ICON plc)
Flatiron Health
Customer Sentiments
Customer sentiment appears positive, as Prognos Health directly addresses key pain points like fragmented data and the need for actionable insights, which aligns with their specialized data offerings and focus on high-value therapeutic areas. Testimonials indicate satisfaction with their ability to provide tailored solutions for commercial analytics and brand marketing needs.
Actionable Insights
To strengthen brand positioning, Prognos Health should showcase more detailed case studies and customer success metrics on its website.
Products and Features
Patient-Centric Medical Data Marketplace - Product Description
Prognos Health offers a marketplace for patient medical data, shifting away from the traditional model of buying entire data sources. This product allows users to acquire patient-centric data, enabling more targeted and efficient data procurement. It focuses on providing specific, relevant patient data rather than large, potentially extraneous datasets, which can lead to cost savings and improved analytical focus.
Pros
- It enables the purchase of highly specific, patient-centric data, reducing unnecessary data acquisition
- This approach can lead to significant cost savings compared to buying entire, often overly broad, data sources
- Access to targeted data improves the efficiency and accuracy of analyses for healthcare and pharmaceutical research.
Cons
- The transition to a patient-centric model might require users to re-evaluate and adapt their existing data acquisition processes
- Companies accustomed to bulk data purchases may find the granular selection process initially more time-consuming
- Data privacy and compliance concerns, while likely addressed, remain a constant challenge in medical data marketplaces.
Alternatives
- Traditional data brokers who sell large, comprehensive medical datasets are a direct alternative to this model
- Pharmaceutical companies and healthcare organizations often have in-house data collection and aggregation capabilities that serve as an alternative
- Other health data platforms focusing on anonymized or aggregated real-world data also compete in this space.
Company Updates
Latest Events at Prognos Health
Home New
Unlock actionable clinical and genomic laboratory data with Prognos Health, enhancing patient outcomes and accelerating commercial analytics for the life ...
View sourcePrognos Health | LinkedIn
Jun 4, 2023 ... Prognos Health is a real-world data (RWD) company that unlocks the power of data to improve health. Prognos offers the leading managed RWD marketplace.
View sourceLivongo & Prognos Partner to Drive More Personalized Health ...
Apr 8, 2020 ... ... important health markers and risk indicators for people with ... Prognos Health is an AI platform company focused on predicting the ...
View sourceOM1 Inc.
Delivering real-world data and insights, digital phenotyping and personalized medicine, and tech-enabled prospective and retrospective evidence generation ...
View sourceTransform Your Ideas into Action in Minutes with WaxWing
Sign up now and unleash the power of AI for your business growth
